Notably, 16 (34%) CD8 T cells dually scored for both Lowery and Meng predictive CD8 signatures, while 10 CD4 T cells were dually identified by both Lowery and Zheng predictive CD4 signatures (58.8% of the Lowery NeoTCR4 and 43.5% of the Zheng ExRe CD4) (Fig. 4D), providing a high-priority consensus list of TCR sequences with potential tumor reactivity. The gene discussed is CD4; the disease is neoplasm.